Hormonal therapy

Some breast cancers are caused due to the hormones in blood. It is a form of systemic therapy it not only reaches the cancer cells present in breast also reaches cancer cells all over the body. Hormonal therapy is recommended for women with hormone receptor-positive breast cancers, it is not useful for the women who are suffering with hormone receptor-negative breast cancer.

Hormonal therapy is often used as adjuvant therapy to reduce the risk of cancer coming back. Sometimes this therapy is started as neoadjuvant therapy. The drugs that stop estrogen from affecting breast cancer cells are,

  • ER-positive cancers
  • PR-positive cancers
  • Adjuvant therapy
  • Neo-adjuvant therapy
  • Breast cancer hormone therapy
  • Prostate cancer hormone therapy
  • Womb cancer hormone therapy

Related Conference of Hormonal therapy

February 05-06, 2026

11th World Conference on Breast and Cervical Cancer

Paris, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 09-10, 2026

4th World Congress on Oral Cancer

Singapore City, Singapore
March 30-31, 2026

26th World Congress on Cancer and Diagnostics

London, UK
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
June 23-24, 2026

27th World Congress on Cancer Summit

Paris, France
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France

Hormonal therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in